Ergoteles LLC Merck & Co., Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $463,113 - $504,772	4,264 New	4,264 $492,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $957,471 - $1.08 Million	11,327 New	11,327 $975,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $36.9 Million - $40.5 Million	-514,388 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $36.2 Million - $40 Million	514,388 New	514,388 $40 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $28.1 Million - $33.1 Million	-407,690 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $29.3 Million - $32.5 Million	407,690 New	407,690 $33.3 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.